|Published||Report Code||Available Format||Pages|
Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation
This report includes the pipeline analysis as of June 2017 to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, combination therapies, targets and mechanism of action and drug origin with relevance to hemophilia.
Hemophilia Therapeutics Pipeline Analysis